Dr. Asea received his Ph.D. in Medical Microbiology and Immunology from the University of Gothenburg, Sweden, where his studies helped form the basis for clinical trials of combined immunotherapy with histamine and interleukin-2 in metastatic melanoma and high-risk acute myelogenous leukemia (AML). Dr. Asea went on to perform postdoctoral training at the University of Miami School of Medicine and the Dana-Farber Cancer Institute and Harvard Medical School.
In 2002, Dr. Asea was appointed the Deputy Director, Center for Molecular Stress Response at Boston University School of Medicine and the Boston Medical Center. Dr. Asea was recruited in 2005 to Scott & White Hospital and the Texas A&M Health Science Center College of Medicine as the Effie and Wofford Cain Centennial Endowed Chair in Clinical Pathology and Director, Division of Investigative Pathology.
Dr. Asea’s research interests center on the role of heat shock proteins in human disease. His initial observations studying the effect of heat shock proteins on human monocytes led to a paradigm shift in our understanding of the role of heat shock proteins. Additional discoveries including the recent finding that surface expression of heat shock proteins differentially regulate tumor growth and metastasis, and that silencing these proteins eliminates the migration capability of the highly metastatic breast adenocarcinoma in vitro and in vivo, have opened a new front in the fight against cancer.
Media mention of Dr. Azea’s Research where can i buy Finax in south africa